Sigma-Aldrich Joins Phase 2 of the RNAi Consortium to Validate shRNA Libraries 09 May 2008 Sigma-Aldrich to provide full functional validation data for its MISSION® shRNA collection.
Invitrogen Scientists Link microRNA Sequences to Cancer Using RNA Samples from BioServe 08 May 2008 Invitrogen and BioServe technologies have identified noncoding RNAs that were differentially expressed in healthy and diseased tissue.
LC Sciences and DNAVision form Strategic Marketing Alliance 07 May 2008 Agreement aims at increasing accessibility to LC Sciences’ custom microRNA profiling service to researchers in Europe.
Regulus Therapeutics Exclusively Licenses Intellectual Property from Stanford University 07 May 2008 Regulus gains right to patent applications covering methods and compositions for antagonizing miR-181a to regulate immune responses.
Getting Wise to the Influenza Virus’s Tricks 06 May 2008 A high-resolution image of an influenza virus protein opens the way to design new anti-viral drugs.
Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate 29 April 2008 Rosetta Genomics in-licenses, on a non-exclusive basis, proprietary MicroRNAs for research applications from Rockefeller University.
Polyplus-transfection Unveils Technology to Improve Intracellular Delivery of Small Interfering RNAs In-vivo 25 April 2008 The "Sticky siRNA" technology is already being tested in vivo by academic laboratories and biotech companies.
Arrowhead Nanobiotechnology Subisidaries, Calando and Insert Complete Merger 25 April 2008 The merger is part of a streamlining of the two companies in which Arrowhead assumed active management to focus resources on bringing multiple products to the clinic as rapidly.
Arutselvan Natarajan wins the award for best poster at MedChem India 24 April 2008 Arutselvan Natarajan, an Assistant Research Professor at University of California, Davis won the award for best poster at MedChem India held in Bangalore 18-19 March 2008.
Calando Receives FDA Approval for Phase I Clinical Trial Using a Targeted siRNA Nanoparticle Therapeutic 22 April 2008 FDA approval to proceed with proprietary RONDEL™ drug delivery system and siRNA combined for first targeted, systemic delivery in oncology phase I clinical trial.
Open Biosystems Launches Decode RNAi Viral Screening Pools for Low-Cost Genome-Scale RNAi Screens 16 April 2008 The offering allows researchers access to genome-scale RNAi screens and the ability to screen through thousands of genes at a time utilizing PCR and traditional sequencing.